Skip to main content

Table 2 Percentage of patients with diabetes and control individuals reporting moderate and severe problems in each EQ-5D dimension by disease duration

From: Diabetes duration and health-related quality of life in individuals with onset of diabetes in the age group 15—34 years – a Swedish population-based study using EQ-5D

  Diabetes duration   
  1 year   8 years   15 years   24 years   Comparison of individuals with diabetes Comparison of control individuals
  (2008 cohort)   (1999 cohort)   (1992 cohort)   (1983 cohort)  
  Individuals with diabetes Control individuals p a Individuals with diabetes Control individuals p a Individuals with diabetes Control individuals p a Individuals with diabetes Control individuals p a
  n = 141 n = 247   n = 208 n = 381   n = 225 n = 419   n = 265 n = 517   p b p c
  % n % n   % n % n   % n % n   % n % n    
Mobility                       
Women                       
 Moderate problems 5.7 3 4.0 4 0.69 6.4 6 3.6 6 0.36 11.7 11 9.3 16 0.54 16.1 18 9.9 19 0.049 0.053 0.053
 Severe problems 0.0 0 0.0 0   0.0 0 0.0 0   0.0 0 0.0 0   0.9 1 0.0 0    
Men                       
 Moderate problems 2.3 2 2.7 4 1.00 2.6 3 5.6 12 0.22 10.7 14 4.9 12 0.033 17.6 27 15.9 50 0.51 <0.001 <0.001
 Severe problems 0.0 0 0.0 0   0.0 0 0.0 0   0.0 0 0.0 0   0.7 1 0.0 0    
Self-care                       
Women                       
 Moderate problems 0.0 0 0.0 0 - 0.0 0 0.6 1 1.00 1.1 1 2.3 4 0.43 2.7 3 0.5 1 0.023 0.048 0.059
 Severe problems 0.0 0 0.0 0   0.0 0 0.0 0   0.0 0 0.6 1   1.8 2 0.0 0    
Men                       
 Moderate problems 1.1 1 0.0 0 0.38 1.8 2 0.9 2 0.61 3.8 5 1.6 4 0.10 3.3 5 1.9 6 0.58 0.37 0.11
 Severe problems 0.0 0 0.0 0   0.0 0 0.0 0   0.8 1 0.0 0   0.7 1 1.0 3    
Usual activities                       
Women                       
 Moderate problems 13.2 7 3.0 3 0.048 12.8 12 7.7 13 0.18 14.9 14 6.4 11 0.029 20.5 23 8.4 16 0.001 0.19 0.42
 Severe problems 0.0 0 1.0 1   0.0 0 0.0 0   2.1 2 1.7 3   2.7 3 1.5 3    
Men                       
 Moderate problems 9.1 8 3.4 5 0.033 4.4 5 6.6 14 0.64 9.9 13 7.7 19 0.31 12.4 19 8.6 27 0.14 0.090 0.065
 Severe problems 2.3 2 0.7 1   1.8 2 0.9 2   2.1 3 1.2 3   3.9 6 2.9 9    
Pain/discomfort                       
Women                       
 Moderate problems 28.3 15 25.7 26 0.35 45.7 43 31.5 53 0.050 48.9 46 35.5 61 0.013 51.8 58 47.5 96 0.33 0.041 <0.001
 Severe problems 5.7 3 1.0 1   1.1 1 3.0 5   5.3 5 2.9 5   4.5 5 3.0 6    
Men                       
 Moderate problems 22.7 20 24.7 36 0.77 28.9 33 32.4 69 0.41 24.4 32 40.1 99 0.012 49.7 76 44.8 141 0.12 <0.001 <0.001
 Severe problems 2.3 2 2.1 3   0.9 1 1.9 4   6.1 8 3.6 9   7.2 11 4.4 14    
Anxiety/depression                       
Women                       
 Moderate problems 32.0 17 30.7 31 0.60 36.2 34 27.4 46 0.13 38.3 36 29.7 51 0.057 46.4 52 36.0 73 0.056 0.29 0.41
 Severe problems 3.8 2 1.0 1   2.1 2 1.8 3   8.5 8 5.2 9   1.8 2 1.0 2    
Men                       
 Moderate problems 28.4 25 23.3 34 0.14 30.7 35 24.9 53 0.13 25.2 33 31.6 78 0.22 31.4 48 23.2 73 0.064 0.43 0.28
 Severe problems 6.8 6 2.7 4   3.5 4 1.4 3   1.5 2 1.2 3   3.3 5 3.2 10    
  1. a P-value for comparison between patients with diabetes and control individuals (χ2 or Fisher exact test), b p-value for comparison between patients with diabetes in the different cohorts (ANOVA), c p-value for comparison between control individuals in the different cohorts (ANOVA).